Regulatory Canvas of Indian Pharmaceutical Industry: Challenges and Future

  • Posted on: 31 May 2016
  • By: admin

 

Magazine Home


June 2016 ARTICLE LIST >>

PharmaTutor (June- 2016)

 

Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 6)

 

Received On: 25/01/2016; Accepted On: 05/02/2016; Published On: 01/06/2016

 

AUTHORS:
Ayushi Srivastava*, Veena Gupta
QC Department,
Akums Drugs & Pharmaceuticals Ltd, Haridwar, India
*ayushisr@gmail.com

 

ABSTRACT: This article undertakes a review and assessment of regulatory framework in the Indian pharmaceutical industry. Understanding the regulatory circumstances in this segment is extremely critical. The Pharmaceutical industry is one of the major industries in India and it contributes a large share in the overall macro level growth of the India. It is one of the most dynamic sectors in the country but its compliance structure is more complex. The pharmaceutical industry has always been a buoyant sector in the eyes of Investors. With increasing returns, lower risks and high growth, investors are more interested in this industry than ever before.

 

How to cite this article: Srivastava A, Gupta V; Regulatory Canvas of Indian Pharmaceutical Industry: Challenges and Future; PharmaTutor; 2016; 4(6); 15-19

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML